These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
213 related articles for article (PubMed ID: 30626837)
1. Development of Propionibacterium acnes-associated Sarcoidosis During Etanercept Therapy. Isshiki T; Matsuyama H; Sakamoto S; Honma N; Mikami T; Shibuya K; Eishi Y; Homma S Intern Med; 2019 May; 58(10):1473-1477. PubMed ID: 30626837 [TBL] [Abstract][Full Text] [Related]
2. New onset sarcoid-like granulomatosis developing during anti-TNF therapy: an under-recognised complication. Tong D; Manolios N; Howe G; Spencer D Intern Med J; 2012 Jan; 42(1):89-94. PubMed ID: 22389903 [TBL] [Abstract][Full Text] [Related]
3. Propionibacterium acnes is the most common bacterium commensal in peripheral lung tissue and mediastinal lymph nodes from subjects without sarcoidosis. Ishige I; Eishi Y; Takemura T; Kobayashi I; Nakata K; Tanaka I; Nagaoka S; Iwai K; Watanabe K; Takizawa T; Koike M Sarcoidosis Vasc Diffuse Lung Dis; 2005 Mar; 22(1):33-42. PubMed ID: 15881278 [TBL] [Abstract][Full Text] [Related]
4. Development of sarcoidosis during etanercept therapy. Ishiguro T; Takayanagi N; Kurashima K; Matsushita A; Harasawa K; Yoneda K; Tsuchiya N; Miyahara Y; Yamaguchi S; Yano R; Tokunaga D; Saito H; Ubukata M; Yanagisawa T; Sugita Y; Kawabata Y Intern Med; 2008; 47(11):1021-5. PubMed ID: 18520114 [TBL] [Abstract][Full Text] [Related]
5. Development of exclusively cutaneous sarcoidosis in patient with rheumatoid arthritis during treatment with etanercept. Vieira MA; Saraiva MI; Silva LK; Fraga RC; Kakizaki P; Valente NY Rev Assoc Med Bras (1992); 2016 Nov; 62(8):718-720. PubMed ID: 27992009 [TBL] [Abstract][Full Text] [Related]
6. [Granulomatous diseases and pathogenic microorganism]. Inoue Y; Suga M Kekkaku; 2008 Feb; 83(2):115-30. PubMed ID: 18326339 [TBL] [Abstract][Full Text] [Related]
7. Development of sarcoidosis in etanercept-treated rheumatoid arthritis patients. Verschueren K; Van Essche E; Verschueren P; Taelman V; Westhovens R Clin Rheumatol; 2007 Nov; 26(11):1969-71. PubMed ID: 17340045 [TBL] [Abstract][Full Text] [Related]
8. Acute kidney injury due to renal sarcoidosis during etanercept therapy: a case report and literature review. Akiyama M; Kaneko Y; Hanaoka H; Kuwana M; Takeuchi T Intern Med; 2015; 54(9):1131-4. PubMed ID: 25948363 [TBL] [Abstract][Full Text] [Related]
9. [Life-threatening hypercalcemia and acute kidney injury induced by etanercept]. Tsevi YM; Aydin S; Durez P; Labriola L Nephrol Ther; 2018 Nov; 14(6):478-482. PubMed ID: 30401463 [TBL] [Abstract][Full Text] [Related]
10. Sarcoidosis during etanercept treatment for rheumatoid arthritis in women with a history of bilateral oophorectomy. Sawahata M; Sigiyama Y; Yamasawa H; Miki A; Yamamoto H; Muto S; Yamamoto H; Bando M Sarcoidosis Vasc Diffuse Lung Dis; 2016 Aug; 33(2):178-81. PubMed ID: 27537723 [TBL] [Abstract][Full Text] [Related]
11. In situ localization of Propionibacterium acnes DNA in lymph nodes from sarcoidosis patients by signal amplification with catalysed reporter deposition. Yamada T; Eishi Y; Ikeda S; Ishige I; Suzuki T; Takemura T; Takizawa T; Koike M J Pathol; 2002 Dec; 198(4):541-7. PubMed ID: 12434425 [TBL] [Abstract][Full Text] [Related]
12. First fatal case of systemic suppurative/necrotizing granulomatous disease following etanercept therapy for psoriasis. Turashvili G; Farmer P J Dermatolog Treat; 2015 Apr; 26(2):124-7. PubMed ID: 24646144 [TBL] [Abstract][Full Text] [Related]
14. Catalase expression of Propionibacterium acnes may contribute to intracellular persistence of the bacterium in sinus macrophages of lymph nodes affected by sarcoidosis. Yamamoto K; Uchida K; Furukawa A; Tamura T; Ishige Y; Negi M; Kobayashi D; Ito T; Kakegawa T; Hebisawa A; Awano N; Takemura T; Amano T; Akashi T; Eishi Y Immunol Res; 2019 Jun; 67(2-3):182-193. PubMed ID: 31187451 [TBL] [Abstract][Full Text] [Related]
15. A Patient with Necrotizing Vasculitis Related to Sarcoidosis, which Was Diagnosed via Immunohistochemical Methods Using Propionibacterium acnes-specific Monoclonal Antibodies. Noda S; Maeda A; Komiya Y; Soejima M Intern Med; 2020 Oct; 59(19):2423-2425. PubMed ID: 32536653 [TBL] [Abstract][Full Text] [Related]
16. Localization of propionibacterium acnes in granulomas supports a possible etiologic link between sarcoidosis and the bacterium. Negi M; Takemura T; Guzman J; Uchida K; Furukawa A; Suzuki Y; Iida T; Ishige I; Minami J; Yamada T; Kawachi H; Costabel U; Eishi Y Mod Pathol; 2012 Sep; 25(9):1284-97. PubMed ID: 22596102 [TBL] [Abstract][Full Text] [Related]
17. Sarcoidosis occuring during anti-TNF-alpha treatment for inflammatory rheumatic diseases: report of two cases. Toussirot E; Pertuiset E; Kantelip B; Wendling D Clin Exp Rheumatol; 2008; 26(3):471-5. PubMed ID: 18578973 [TBL] [Abstract][Full Text] [Related]
18. Propionibacterium acnes-associated neurosarcoidosis: A case report with review of the literature. Yang G; Eishi Y; Raza A; Rojas H; Achiriloaie A; De Los Reyes K; Raghavan R Neuropathology; 2018 Apr; 38(2):159-164. PubMed ID: 28856748 [TBL] [Abstract][Full Text] [Related]
19. Induction of Pulmonary Granuloma Formation by Propionibacterium acnes Is Regulated by MyD88 and Nox2. Werner JL; Escolero SG; Hewlett JT; Mak TN; Williams BP; Eishi Y; Núñez G Am J Respir Cell Mol Biol; 2017 Jan; 56(1):121-130. PubMed ID: 27607191 [TBL] [Abstract][Full Text] [Related]
20. [Case Report; Long-term treatment with etanercept induced systemic sarcoidosis in a patient with rheumatoid arthritis]. Yokoe I; Haraoka H; Yonamine T; Sato R; Nishiwaki A; Takei M Nihon Naika Gakkai Zasshi; 2015 Apr; 104(4):769-74. PubMed ID: 26536740 [No Abstract] [Full Text] [Related] [Next] [New Search]